Linde PLC (LIN) stock
LINNasdaqIndustrial Inorganic ChemicalsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 14/3026% above fair value
$522.49−4.06 (-0.77%)
Close on Nov 12, 2026Market cap $239.87BP/E 34.7Yield 1.15%
Linde ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Linde's ebitda for the twelve months ending Sep 30, 2026 was $12.99B, up 0.7% year over year. For fiscal 2025 it was $12.69B, up 2.2% from the year before. The highest annual figure on record is $12.69B in fiscal 2025.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $12.69B | +2.2% |
| FY2024 | Dec 31, 2024 | $12.42B | +4.9% |
| FY2023 | Dec 31, 2023 | $11.84B | +23.7% |
| FY2022 | Dec 31, 2022 | $9.57B | -0.5% |
| FY2021 | Dec 31, 2021 | $9.62B | +21.0% |
| FY2020 | Dec 31, 2020 | $7.95B | +4.5% |
| FY2019 | Dec 31, 2019 | $7.61B | +7.5% |
| FY2018 | Dec 31, 2018 | $7.08B | +95.1% |
| FY2017 | Dec 31, 2017 | $3.63B | +7.7% |
| FY2016 | Dec 31, 2016 | $3.37B | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $3.12B | -6.4% |
| Q2 FY2026 | Jun 30, 2026 | $3.52B | +6.7% |
| Q1 FY2026 | Mar 31, 2026 | $3.39B | +9.6% |
| Q4 FY2025 | Dec 31, 2025 | $2.97B | -6.8% |
| Q3 FY2025 | Sep 30, 2025 | $3.33B | +9.3% |
| Q2 FY2025 | Jun 30, 2025 | $3.30B | +4.9% |
| Q1 FY2025 | Mar 31, 2025 | $3.09B | +1.6% |
| Q4 FY2024 | Dec 31, 2024 | $3.18B | +6.9% |
| Q3 FY2024 | Sep 30, 2024 | $3.05B | +1.2% |
| Q2 FY2024 | Jun 30, 2024 | $3.14B | +5.8% |
| Q1 FY2024 | Mar 31, 2024 | $3.04B | +5.7% |
| Q4 FY2023 | Dec 31, 2023 | $2.98B | +12.6% |
| Q3 FY2023 | Sep 30, 2023 | $3.01B | +13.3% |
| Q2 FY2023 | Jun 30, 2023 | $2.97B | +76.8% |
| Q1 FY2023 | Mar 31, 2023 | $2.88B | +11.1% |
| Q4 FY2022 | Dec 31, 2022 | $2.64B | +6.9% |
| Q3 FY2022 | Sep 30, 2022 | $2.66B | +8.3% |
| Q2 FY2022 | Jun 30, 2022 | $1.68B | -27.4% |
| Q1 FY2022 | Mar 31, 2022 | $2.59B | +9.0% |
| Q4 FY2021 | Dec 31, 2021 | $2.47B | +11.3% |
| Q3 FY2021 | Sep 30, 2021 | $2.46B | +14.9% |
| Q2 FY2021 | Jun 30, 2021 | $2.31B | +34.9% |
| Q1 FY2021 | Mar 31, 2021 | $2.38B | +26.9% |
| Q4 FY2020 | Dec 31, 2020 | $2.22B | +22.2% |
| Q3 FY2020 | Sep 30, 2020 | $2.14B | +2.0% |
| Q2 FY2020 | Jun 30, 2020 | $1.72B | -8.0% |
| Q1 FY2020 | Mar 31, 2020 | $1.88B | +2.3% |
| Q4 FY2019 | Dec 31, 2019 | $1.82B | -56.1% |
| Q3 FY2019 | Sep 30, 2019 | $2.10B | +114.9% |
| Q2 FY2019 | Jun 30, 2019 | $1.86B | +86.4% |
| Q1 FY2019 | Mar 31, 2019 | $1.83B | +90.0% |
| Q4 FY2018 | Dec 31, 2018 | $4.14B | +337.4% |
| Q3 FY2018 | Sep 30, 2018 | $975.00M | +4.8% |
| Q2 FY2018 | Jun 30, 2018 | $1.00B | +11.4% |
| Q1 FY2018 | Mar 31, 2018 | $964.00M | +12.9% |
| Q4 FY2017 | Dec 31, 2017 | $946.00M | – |
| Q3 FY2017 | Sep 30, 2017 | $930.00M | – |
| Q2 FY2017 | Jun 30, 2017 | $898.00M | – |
| Q1 FY2017 | Mar 31, 2017 | $854.00M | – |
See a number that looks wrong?